Patents by Inventor Steven P. Adams
Steven P. Adams has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20180133170Abstract: Compounds and compositions for treating disorders related to TRPA1 are described herein.Type: ApplicationFiled: June 30, 2017Publication date: May 17, 2018Inventors: Manfred Weigele, Jayhong A. Chong, Glenn R. Larsen, Neil J. Hayward, Amy Ripka, Howard Ng, Magdalene M. Moran, Christopher Fanger, Donato Del Camino, Steven P. Adams
-
Publication number: 20130059869Abstract: Compounds and compositions for treating disorders related to TRPA1 are described herein.Type: ApplicationFiled: February 22, 2012Publication date: March 7, 2013Inventors: Howard Ng, Manfred Weigele, Magdalene Moran, Jayhong Chong, Christopher Fanger, Glenn R. Larsen, Donato Del Camino, Neil Hayward, Steven P. Adams, Amy Ripka
-
Publication number: 20130011390Abstract: Methods of, and compositions for, treating central nervous system injury with an antagonist of an alpha4 subunit containing integrin are described.Type: ApplicationFiled: June 6, 2012Publication date: January 10, 2013Applicant: BIOGEN IDEC MA INC.Inventors: Jane Relton, Roy R. Lobb, Eric Whalley, Steven P. Adams
-
Patent number: 8163761Abstract: Compounds and compositions for treating disorders related to TRPA1 are described herein.Type: GrantFiled: June 23, 2008Date of Patent: April 24, 2012Assignee: Hydra Biosciences, Inc.Inventors: Howard Ng, Manfred Weigele, Magdalene Moran, Jayhong Chong, Christopher Fanger, Glenn R. Larsen, Donato Del Camino, Neil Hayward, Steven P. Adams, Amy Ripka
-
Publication number: 20090143377Abstract: Compounds and compositions for treating disorders related to TRPA1 are described herein.Type: ApplicationFiled: June 23, 2008Publication date: June 4, 2009Inventors: Howard Ng, Manfred Weigele, Magdalene Moran, Jayhong Chong, Christopher Fanger, Glenn R. Larsen, Donato Del Camino, Neil Hayward, Steven P. Adams, Amy Ripka
-
Patent number: 7001921Abstract: The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of using them for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. The compounds and pharmaceutical compositions of this invention can be used as therapeutic or prophylactic agents. They are particularly well-suited for treatment of many inflammatory and autoimmune diseases.Type: GrantFiled: July 24, 2003Date of Patent: February 21, 2006Assignee: Biogen Idec MA Inc.Inventors: Steven P. Adams, Ko-Chung Lin, Wen-Cherng Lee, Alfredo C. Castro, Craig N. Zimmerman, Charles E. Hammond, Yu-Sheng Liao
-
Patent number: 6949534Abstract: The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of using them for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. The compounds and pharmaceutical compositions of this invention can be used as therapeutic or prophylactic agents. They are particularly well-suited for treatment of many inflammatory and autoimmune diseases.Type: GrantFiled: October 1, 2002Date of Patent: September 27, 2005Assignee: Biogen Idec MA Inc.Inventors: Zhongli Zheng, Carol L. Ensinger, Steven P. Adams
-
Patent number: 6875743Abstract: The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of using them for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. The compounds and pharmaceutical compositions of this invention can be used as therapeutic or prophylactic agents. They are particularly well-suited for treatment of many inflammatory and autoimmune diseases.Type: GrantFiled: November 28, 2000Date of Patent: April 5, 2005Assignee: Biogen, Inc.Inventors: Ko-Chung Lin, Steven P. Adams, Alfredo C. Castro, Craig N. Zimmerman, Julio Hernan Cuervo, Wen-Cherng Lee, Charles E. Hammond, Mary Beth Carter, Ronald G. Almquist
-
Patent number: 6710237Abstract: A drum pedal for enhanced mating of a drummer's foot is disclosed. In a preferred embodiment, a foot pad is employed for attachment to a pedal of a drum having an upwardly extending protrusion that enables improved sensory perception to properly locate a drummer's foot and to enable learning and consistently applying a force to a sweet spot during drumming. The foot pad also includes shock absorption to reduce the negative effects of repeated impact to the user's foot during drumming. A variety of embodiments include traction treads, a plurality of protrusions or built up portions in different respective locations of the footpad, and an additional stiffening layer to effectively widen the foot pedal. A method of use includes locating the foot pad on a the foot pedal, and in particular locating a protrusion on the foot pedal to enable consistent drumming by improved sensory perception and positioning of a drummer's foot during drumming.Type: GrantFiled: February 19, 2002Date of Patent: March 23, 2004Inventor: Steven P. Adams
-
Publication number: 20040053907Abstract: The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of using them for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. The compounds and pharmaceutical compositions of this invention can be used as therapeutic or prophylactic agents. They are particularly well-suited for treatment of many inflammatory and autoimmune diseases.Type: ApplicationFiled: October 1, 2002Publication date: March 18, 2004Applicant: Biogen, Inc. a Massachusetts Corporation.Inventors: Zhongli Zheng, Carol L. Ensinger, Steven P. Adams
-
Patent number: 6686350Abstract: The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of using them for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. The compounds and pharmaceutical compositions of this invention can be used as therapeutic or prophylactic agents. They are particularly well-suited for treatment of many inflammatory and autoimmune diseases.Type: GrantFiled: January 25, 1999Date of Patent: February 3, 2004Assignee: Biogen, Inc.Inventors: Zhongli Zheng, Carol L. Ensinger, Steven P. Adams
-
Patent number: 6630512Abstract: The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of using them for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. The compounds and pharmaceutical compositions of this invention can be used as therapeutic or prophylactic agents. They are particularly well-suited for treatment of many inflammatory and autoimmune diseases.Type: GrantFiled: October 23, 2001Date of Patent: October 7, 2003Assignee: Biogen, Inc.Inventors: Steven P. Adams, Ko-Chung Lin, Wen-Cherng Lee, Alfredo C. Castro, Craig N. Zimmerman, Charles E. Hammond, Yu-Sheng Liao, Julio Hernan Cuervo, Juswinder Singh
-
Patent number: 6624152Abstract: The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of using them for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. The compounds and pharmaceutical compositions of this invention can be used as therapeutic or prophylactic agents. They are particularly well-suited for treatment of many inflammatory and autoimmune diseases.Type: GrantFiled: August 22, 2001Date of Patent: September 23, 2003Assignee: Biogen, Inc.Inventors: Steven P. Adams, Ko-Chung Lin, Wen-Cherng Lee, Alfredo C. Castro, Craig N. Zimmerman, Charles E. Hammond, Yu-Sheng Liao
-
Publication number: 20030154846Abstract: A foot pad for attachment to a pedal of a drum has an upwardly extending protrusion that enables improved sensory perception to properly locate a drummer's foot and to enable learning and consistently applying a force to a sweet spot during drumming. The foot pad also includes shock absorption to reduce the negative effects of repeated impact to the user's foot during drumming. A variety of embodiments include traction treads, a plurality of protrusions or built up portions in different respective locations of the foot pad, and an additional stiffening layer to effectively widen the foot pedal. A method of use includes locating the foot pad on a the foot pedal, and in particular locating a protrusion on the foot pedal to enable consistent drumming by improved sensory perception and positioning of a drummer's foot during drumming.Type: ApplicationFiled: February 19, 2002Publication date: August 21, 2003Inventor: Steven P. Adams
-
Patent number: 6596687Abstract: The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of using them for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. The compounds and pharmaceutical compositions of this invention can be used as therapeutic or prophylactic agents. They are particularly well-suited for treatment of many inflammatory and autoimmune diseases.Type: GrantFiled: January 13, 2000Date of Patent: July 22, 2003Assignee: Biogen, Inc.Inventors: Ko-Chung Lin, Steven P. Adams, Alfredo C. Castro, Craig N. Zimmerman, Julio Hernan Cuervo, Wen-Cherng Lee, Charles E. Hammond, Mary Beth Carter, Ronald G. Almquist
-
Publication number: 20030083267Abstract: The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of using them for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. The compounds and pharmaceutical compositions of this invention can be used as therapeutic or prophylactic agents. They are particularly well-suited for treatment of many inflammatory and autoimmune diseases.Type: ApplicationFiled: August 22, 2001Publication date: May 1, 2003Applicant: Biogen, Inc., a Massachusetts corporationInventors: Steven P. Adams, Ko-Chung Lin, Wen-Cherng Lee, Alfredo C. Castro, Craig N. Zimmerman, Charles E. Hammond, Yu-Sheng Liao
-
Patent number: 6552216Abstract: Pharmacophore models of VLA-4 inhibitors, methods of identifying novel inhibitors and novel inhibitors identified by these methods.Type: GrantFiled: January 25, 1999Date of Patent: April 22, 2003Assignee: Biogen, Inc.Inventors: Juswinder Singh, Zhongli Zheng, Peter Sprague, Herman Van Vlijmen, Alfredo Castro, Steven P. Adams
-
Publication number: 20030018016Abstract: The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of using them for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. The compounds and pharmaceutical compositions of this invention can be used as therapeutic or prophylactic agents. They are particularly well-suited for treatment of many inflammatory and autoimmune diseases.Type: ApplicationFiled: October 23, 2001Publication date: January 23, 2003Inventors: Steven P. Adams, Ko-Chung Lin, Wen-Cherng Lee, Alfredo C. Castro, Craig N. Zimmerman, Charles E. Hammond, Yu-Sheng Liao, Julio Hernan Cuervo, Juswinder Singh
-
Publication number: 20020197233Abstract: Methods of, and compositions for, treating central nervous system injury with an antagonist of an alpha4 subunit containing integrin are described.Type: ApplicationFiled: June 13, 2002Publication date: December 26, 2002Inventors: Jane Relton, Roy Lobb, Eric Whalley, Steven P. Adams
-
Patent number: 6376538Abstract: The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of using them for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. The compounds and pharmaceutical compositions of this invention can be used as therapeutic or prophylactic agents. They are particularly well-suited for treatment of many inflammatory and autoimmune diseases.Type: GrantFiled: September 19, 1997Date of Patent: April 23, 2002Assignee: Biogen, Inc.Inventors: Steven P. Adams, Ko-Chung Lin, Wen-Cherng Lee, Alfredo C. Castro, Craig N. Zimmerman, Charles E. Hammond, Yu-Sheng Liao, Julio Hernan Cuervo, Juswinder Singh